Costs, effects and cost‐effectiveness of breast cancer control in Ghana
Open Access
- 19 July 2012
- journal article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 17 (8), 1031-1043
- https://doi.org/10.1111/j.1365-3156.2012.03021.x
Abstract
Objective Breast cancer control in Ghana is characterised by low awareness, late-stage treatment and poor survival. In settings with severely constrained health resources, there is a need to spend money wisely. To achieve this and to guide policy makers in their selection of interventions, this study systematically compares costs and effects of breast cancer control interventions in Ghana. Methods We used a mathematical model to estimate costs and health effects of breast cancer interventions in Ghana from the healthcare perspective. Analyses were based on the WHO-CHOICE method, with health effects expressed in disability-adjusted life years (DALYs), costs in 2009 US dollars (US$) and cost-effectiveness ratios (CERs) in US$ per DALY averted. Analyses were based on local demographic, epidemiological and economic data, to the extent these data were available. Results Biennial screening by clinical breast examination (CBE) of women aged 40–69 years, in combination with treatment of all stages, seems the most cost-effective intervention (costing $1299 per DALY averted). The intervention is also economically attractive according to international standards on cost-effectiveness. Mass media awareness raising (MAR) is the second best option (costing $1364 per DALY averted). Mammography screening of women of aged 40–69 years (costing $12 908 per DALY averted) cannot be considered cost-effective. Conclusions Both CBE screening and MAR seem economically attractive interventions. Given the uncertainty about the effectiveness of these interventions, only their phased introduction, carefully monitored and evaluated, is warranted. Moreover, their implementation is only meaningful if the capacity of basic cancer diagnostic, referral and treatment and possibly palliative services is simultaneously improved.Keywords
This publication has 36 references indexed in Scilit:
- Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010The Lancet Oncology, 2011
- Breast Cancer in Developing Countries: Opportunities for Improved SurvivalJournal of Oncology, 2010
- The costs of breast cancer prior to and following diagnosisThe European Journal of Health Economics, 2010
- Setting up home-based palliative care in countries with limited resources: a model from Sarawak, MalaysiaAnnals Of Oncology, 2008
- Practical Applications for Clinical Breast Examination (CBE) and Breast Self-Examination (BSE) in Screening and Early Detection of Breast CancerBreast Care, 2008
- Kerala, India: A Regional Community-Based Palliative Care ModelJournal of Pain and Symptom Management, 2007
- Comparing Hospice and Nonhospice Patient Survival Among Patients Who Die Within a Three-Year WindowJournal of Pain and Symptom Management, 2007
- Symptom clustering in advanced cancerSupportive Care in Cancer, 2006
- False-positive mammograms—can the USA learn from Europe?The Lancet, 2005
- Breast Cancer ManagementPharmacoEconomics, 2003